The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 27, 2019
Filed:
Feb. 20, 2018
Applicant:
Sanofi, Paris, FR;
Inventors:
Lothar Schwink, Frankfurt am Main, DE;
Christian Buning, Frankfurt am Main, DE;
Heiner Glombik, Frankfurt am Main, DE;
Christoph Pöverlein, Frankfurt am Main, DE;
Kurt Ritter, Frankfurt am Main, DE;
Nis Halland, Frankfurt am Main, DE;
Matthias Lohmann, Frankfurt am Main, DE;
Assignee:
SANOFI, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/14 (2006.01); A61K 31/444 (2006.01); A61K 45/06 (2006.01); A61K 31/506 (2006.01); A61K 31/7008 (2006.01); C07D 417/14 (2006.01); A61K 31/155 (2006.01); A61K 31/351 (2006.01); A61K 31/397 (2006.01); C07D 487/10 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/155 (2013.01); A61K 31/351 (2013.01); A61K 31/397 (2013.01); A61K 31/444 (2013.01); A61K 31/506 (2013.01); A61K 31/7008 (2013.01); A61K 45/06 (2013.01); C07D 403/14 (2013.01); C07D 417/14 (2013.01); C07D 487/10 (2013.01);
Abstract
The present disclosure relates to azetidine compounds. The azetidine compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The present disclosure furthermore relates to the use of azetidine compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.